tirzepatide court Connecticut Attorney General warning about the use of non-FDA approved weight-loss injections, consequences UPDATE [March 7, 2025]: OFA

In this episode, they address common questions about this popular medications impact on weight loss, hormone health, reproductive health and potential side effects

Methods: This study extracted adverse event reports of GLP-1 RA-induced cholecystitis and cholelithiasis from the FDA Adverse Event Reporting System database, covering Q1 2004 to Q2 2024

Tirzepatide is administered as a once-weekly subcutaneous injection, starting at 2.5 mg for 4 weeks and then increasing in 2.5 mg increments to a maintenance dose of 5-15 mg based on clinical response and tolerability

Cost: $$$ - Often $100-200/session without insurance

For ER66 staining, the scores were assigned according to the intensity and percentage of the cancer cells with nuclear staining

However, STD insurance does not provide job protection or a guarantee that you will have the same position when you return